Tesamorelin Dosage
Medically reviewed by Drugs.com. Last updated on Aug 7, 2023.
Applies to the following strengths: 1 mg; 2 mg
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Lipodystrophy
2 mg subcutaneously once a day
Comments:
- Long term cardiovascular safety and benefit have not been studied.
- Not indicated for weight loss (weight neutral effect).
- There are no data to support improved compliance with anti-retroviral therapies in HIV positive patients.
Use(s): Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
- Disruption of the hypothalamic-pituitary axis due to hypophysectomy, hypopituitarism, pituitary tumor/surgery, head irradiation, or head trauma
- Active malignancy (newly diagnosed or recurrent)
- Hypersensitivity to tesamorelin and/or mannitol (an excipient)
- Pregnancy
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Administer into abdominal skin subcutaneously, rotating sites.
- Do not inject into scar tissue, bruises, or the navel.
More about tesamorelin
- Check interactions
- Compare alternatives
- Reviews (17)
- Side effects
- During pregnancy
- Drug class: growth hormones
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.